| 1 | ARWRARROWHEAD PHARMACEUTICALS, INC. | 100 | 23258% | -44% | $11.8B | — |
| 2 | MDGLMADRIGAL PHARMACEUTICALS, INC. | 98 | 432% | -27% | $12.2B | — |
| 3 | ASNDAscendis Pharma A/S | 97 | 98% | -32% | $18.0B | — |
| 4 | ALNYALNYLAM PHARMACEUTICALS, INC. | 95 | 65% | 8% | $41.8B | 6 |
| 5 | KRYSKrystal Biotech, Inc. | 94 | 34% | 54% | $11.1B | — |
| 6 | LLYELI LILLY & Co | 92 | 45% | 32% | $1.1T | 8 |
| 7 | AXSMAxsome Therapeutics, Inc. | 91 | 66% | -27% | $12.6B | — |
| 8 | ONCBeOne Medicines Ltd. | 89 | 40% | 5% | $30.9B | 7 |
| 9 | BBIOBridgeBio Pharma, Inc. | 88 | 126% | -126% | $15.1B | 2 |
| 10 | RPRXRoyalty Pharma plc | 86 | 5% | 56% | $25.6B | — |
| 11 | CFCF Industries Holdings, Inc. | 85 | 19% | 29% | $17.0B | 8 |
| 12 | UTHRUNITED THERAPEUTICS Corp | 83 | 11% | 41% | $23.6B | 8 |
| 13 | GMABGENMAB A/S | 82 | 19% | 26% | $17.5B | — |
| 14 | NBIXNEUROCRINE BIOSCIENCES INC | 80 | 21% | 22% | $17.5B | 6 |
| 15 | VRTXVERTEX PHARMACEUTICALS INC / MA | 79 | 9% | 36% | $134.0B | 6 |
| 16 | EXELEXELIXIS, INC. | 77 | 7% | 34% | $14.0B | 6 |
| 17 | NVONOVO NORDISK A S | 76 | 6% | 33% | $223.2B | — |
| 18 | IDXXIDEXX LABORATORIES INC /DE | 74 | 10% | 25% | $44.0B | 7 |
| 19 | RDYDR REDDYS LABORATORIES LTD | 73 | 14% | 18% | $12.0B | — |
| 20 | AMGNAMGEN INC | 71 | 10% | 21% | $201.9B | 7 |
| 21 | GILDGILEAD SCIENCES, INC. | 70 | 2% | 31% | $163.0B | 8 |
| 22 | ZTSZoetis Inc. | 68 | 2% | 28% | $31.4B | 6 |
| 23 | REGNREGENERON PHARMACEUTICALS, INC. | 67 | 1% | 30% | $68.6B | — |
| 24 | JNJJOHNSON & JOHNSON | 65 | 6% | 22% | $633.2B | 4 |
| 25 | AZNASTRAZENECA PLC | 64 | 9% | 17% | $302.7B | — |